The evolving significance of community oncology in the future landscape of cancer treatment is truly noteworthy. Sponsored by McKesson, on February 9, 2026, at 8:00 AM, this discussion sheds light on a pivotal transformation occurring in cancer care.
Did you know that over half of all cancer patients in the United States are now receiving their treatment in community-based settings? This trend signifies a profound change driven by advancements in medical science and the way healthcare is delivered. In this episode of The Top Line, Kirk Kaminsky—who serves as the executive vice president and group president of North American Pharmaceutical Services for McKesson—shares insights into why community oncology has emerged as a fundamental aspect of contemporary cancer care.
As cancer diagnoses become more accurate and patients enjoy longer survival rates, the ability to receive care nearer to home presents substantial benefits not only for patients but also for the broader healthcare system. Kaminsky elaborates on how the swift advancement of innovation is reshaping community oncology practices, introducing new challenges related to reimbursement and operational management.
Furthermore, he discusses how McKesson, alongside The US Oncology Network, is empowering healthcare providers with cutting-edge technology, administrative support, and patient-oriented resources. This strategic support enables oncologists to devote more time to patient care instead of getting bogged down by administrative complexities.
In addition, the conversation delves into the growing involvement of community oncology in clinical trials and the integration of artificial intelligence to optimize workflows and alleviate administrative burdens. Kaminsky offers his vision for the future of cancer treatment and emphasizes the critical need for continuous investment in community oncology practices.
To gain a deeper understanding of these insights and the future trajectory of cancer care, be sure to listen to the complete interview. It’s an enlightening discussion that could spark different opinions about the future of cancer treatment and the role of community settings within it.
